Basal ganglia-cortical structural connectivity in Huntington's disease

Human Brain Mapping

Volumn 36, Issue 5, 2015, Pages 1728-1740

  Novak, Marianne J U ^a   Seunarine, Kiran K ^b   Gibbard, Clare R ^a,b   Mccolgan, Peter ^a   Draganski, Bogdan ^c,d   Friston, Karl ^a   Clark, Chris A ^b   Tabrizi, Sarah J ^a,e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^e NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Basal ganglia; Connectivity; Cortical; Diffusion MRI; Huntington's disease; Tractography

Indexed keywords

ADULT; ARTICLE; ASSESSMENT OF HUMANS; BALTIMORE APATHY AND IRRITABILITY SCALE; BECK DEPRESSION INVENTORY; BRAIN REGION; BRAIN TISSUE; CAG REPEAT; CLINICAL ARTICLE; COGNITION; COMPARATIVE STUDY; CONNECTOME; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DISEASE SEVERITY; FEMALE; FRONTAL SYSTEMS BEHAVIOUR SCALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HUNTINGTON CHOREA; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; UNIFIED HUNTINGTON DISEASE RATING SCALE; BASAL GANGLION; CORPUS STRIATUM; GENETICS; IMAGE PROCESSING; MIDDLE AGED; NERVE TRACT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SEVERITY OF ILLNESS INDEX; TRINUCLEOTIDE REPEAT;

ADULT; BASAL GANGLIA; CORPUS STRIATUM; FEMALE; HUMANS; HUNTINGTON DISEASE; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURAL PATHWAYS; SEVERITY OF ILLNESS INDEX; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84927617517     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22733     Document Type: Article

References (62)

1. Ashburner J (2007): A fast diffeomorphic image registration algorithm. Neuroimage 38:95-113.
2. Aylward EH, Brandt J, Codori AM, Mangus RS, Barta PE, Harris GJ (1994): Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. Neurology 44:823-828.
3. Basser PJ, Mattiello J, LeBihan D (1994): Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson Series B 103:247-254.
4. Beck ATS, RA; Brown, GK (1996): Manual for the Beck Depression Inventory-II, Vol. 1. San Antonio, TX: Psychological Corporation. p 82.
5. Bohanna I, Georgiou-Karistianis N, Egan GF (2011a): Connectivity-based segmentation of the striatum in Huntington's disease: Vulnerability of motor pathways. Neurobiol Dis 42:475-481.
6. Bohanna I, Georgiou-Karistianis N, Sritharan A, Asadi H, Johnston L, Churchyard A, Egan G (2011b): Diffusion tensor imaging in Huntington's disease reveals distinct patterns of white matter degeneration associated with motor and cognitive deficits. Brain Imaging Behav 5:171-180
7. Catani M, ffytche DH (2005): The rises and falls of disconnection syndromes. Brain 128:2224-2239.
8. Chatterjee A, Anderson KE, Moskowitz CB, Hauser WA, Marder KS (2005): A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington's disease. J Neuropsychiatry Clin Neurosci 17:378-383.
9. Cook PA, Bai Y, Nedjati-Gilani S, Seunarine KK, Hall MG, Parker GJ, Alexander DC (2006): Camino: Open source diffusion-MRI reconstruction and processing. In: 14th Scientific Meeting of the International Society for Magnetic Resonance in Medicine, Seattle, WA, USA. p 2759
10. Della Nave R, Ginestroni A, Tessa C, Giannelli M, Piacentini S, Filippi M, Mascalchi M (2010): Regional distribution and clinical correlates of white matter structural damage in Huntington Disease: A tract-based spatial statistics study. Am J Neuroradiol 31:1675.
11. Delmaire C, Dumas EM, Sharman MA, van den Bogaard SJ, Valabregue R, Jauffret C, Justo D, Reilmann R, Stout JC, Craufurd D, Tabrizi SJ, Roos RA, Durr A, Lehéricy S (2013): The structural correlates of functional deficits in early huntington's disease. Hum Brain Mapp 34:2141-2153.
12. Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ (2006): An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31:968-980.
13. Di Paola M, Luders E, Cherubini A, Sanchez-Castaneda C, Thompson PM, Toga AW, Caltagirone C, Orobello S, Elifani F, Squitieri F, Sabatini U (2012): Multimodal MRI analysis of the corpus callosum reveals white matter differences in presymptomatic and early Huntington's disease. Cereb Cortex 22:2858-2866.
14. Douaud G, Behrens TE, Poupon C, Cointepas Y, Jbabdi S, Gaura V, Golestani N, Krystkowiak P, Verny C, Damier P, Bachoud-Lévi AC, Hantraye P, Remy P (2009): In vivo evidence for the selective subcortical degeneration in Huntington's disease. Neuroimage 46: 958-966.
15. Draganski B, Kherif F, Kloppel S, Cook PA, Alexander DC, Parker GJ, Deichmann R, Ashburner J, Frackowiak RS (2008): Evidence for segregated and integrative connectivity patterns in the human Basal Ganglia. J Neurosci 28:7143-7152.
16. Dumas EM, van den Bogaard SJ, Ruber ME, Reilman RR, Stout JC, Craufurd D, Hicks SL, Kennard C, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA (2012): Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease. Hum Brain Mapp 33:203-212.
17. Friston KJ (2007): Functional connectivity: Eigenimages and multivariate analyses In: Friston KJ, Ashburner JT, Kiebel S, Nichols T, Penny WD. Statistical Parametric Mapping: The Analysis of Functional Brain Images, Academic Press, London. pp 492-507.
18. Friston KJ, Frith CD, Frackowiak RS, Turner R (1995): Characterizing dynamic brain responses with fMRI: A multivariate approach. Neuroimage 2:166-172.
19. Friston KJ, Poline JB, Holmes AP, Frith CD, Frackowiak RS (1996): A multivariate analysis of PET activation studies. Hum Brain Mapp 4:140-151.
20. Georgiou-Karistianis N, Gray MA, Dominguez DJ, Dymowski AR, Bohanna I, Johnston LA, Churchyard A, Chua P, Stout JC, Egan GF (2013): Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: The IMAGE-HD study. Neurobiol Dis, 51:82-92.
21. Gioia GA, Isquith PK, Guy SC, Kenworthy L (2000): Behavior rating inventory of executive function. Child Neuropsychol 6:235-238.
22. Gray JM, Young AW, Barker WA, Curtis A, Gibson D (1997): Impaired recognition of disgust in Huntington's disease gene carriers. Brain 120 (Pt 11):2029-2038.
23. Gray MA, Egan GF, Ando A, Churchyard A, Chua P, Stout JC, Georgiou-Karistianis N (2013): Prefrontal activity in Huntington's disease reflects cognitive and neuropsychiatric disturbances: The IMAGE-HD study. Exp Neurol 239:218-228.
24. Hennenlotter A, Schroeder U, Erhard P, Haslinger B, Stahl R, Weindl A, von Einsiedel HG, Lange KW, Ceballos-Baumann AO (2004): Neural correlates associated with impaired disgust processing in pre-symptomatic Huntington's disease. Brain 127:1446-1453.
25. Huntington Study Group (1996): Unified Huntington's Disease Rating Scale: Reliability and consistency. Mov Disord 11:136-142.
26. Jansons KM, Alexander DC (2003): Persistent angular structure: New insights from diffusion magnetic resonance imaging data. Inverse Problems 19:1031-1046.
27. Kloppel S, Draganski B, Golding CV, Chu C, Nagy Z, Cook PA, Hicks SL, Kennard C, Alexander DC, Parker GJ, Tabrizi SJ, Frackowiak RS (2008): White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. Brain 131:196-204.
28. Kloppel S, Stonnington CM, Petrovic P, Mobbs D, Tuscher O, Craufurd D, Tabrizi SJ, Frackowiak RSJ (2010): Irritability in pre-clinical Huntington's disease. Neuropsychologia 48:549-557.
29. Magnotta VA, Kim J, Koscik T, Beglinger LJ, Espinso D, Langbehn D, Nopoulos P, Paulsen JS (2009): Diffusion tensor imaging in preclinical Huntington's disease. Brain Imaging Behav 3:77-84.
30. Mandelli ML, Savoiardo M, Minati L, Mariotti C, Aquino D, Erbetta A, Genitrini S, Di Donato S, Bruzzone MG, Grisoli M (2010): Decreased diffusivity in the caudate nucleus of presymptomatic huntington disease gene carriers: Which explanation? AJNR Am J Neuroradiol 31:706-710.
31. Marrakchi-Kacem L, Delmaire C, Tucholka A, Roca P, Guevara P, Poupon F, Yelnik J, Durr A, Mangin JF, Lehericy S, Poupon C (2010): Analysis of the striato-thalamo-cortical connectivity on the cortical surface to infer biomarkers of Huntington's disease. In: Medical image computing and computer-assisted intervention: MICCAI. International Conference on Medical Image Computing and Computer-Assisted Intervention, Vol. 13. pp 217-224.
32. Marrakchi-Kacem L, Delmaire C, Guevara P, Poupon F, Lecompte S, Tucholka A Roca P, Yelnik J, Durr A, Mangin JF, Lehericy S, Poupon C. (2013): Mapping cortico-striatal connectivity onto the cortical surface: A new tractography-based approach to study Huntington disease. PLoS One 8:e53135.
33. Mascalchi M, Lolli F, Della Nave R, Tessa C, Petralli R, Gavazzi C, Politi LS, Macucci M, Filippi M, Piacentini S (2004): Huntington disease: Volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. Radiology 232:867-873.
34. Novak MJ, Warren JD, Henley SM, Draganski B, Frackowiak RS, Tabrizi SJ (2012): Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease. Brain 135:1165-1179.
35. Parker GJ, Alexander DC (2003): Probabilistic Monte Carlo based mapping of cerebral connections utilising whole-brain crossing fibre information. In: Taylor, CJ and Noble, JA (eds) Information Processing in Medical Imaging. LNCS vol 2732, pp684-695. Springer, Heidelberg.
36. Paulsen JS, Zimbelman JL, Hinton SC, Langbehn DR, Leveroni CL, Benjamin ML, Reynolds NC, Rao SM (2004): fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease. AJNR Am J Neuroradiol 25:1715-1721.
37. Penney JB, Jr., Vonsattel JP, MacDonald ME, Gusella JF, Myers RH (1997): CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 41:689-692.
38. Poudel GR, Stout JC, Dominguez DJ, Salmon L, Churchyard A, Chua P, Georgiou-Karistianis N, Egan GF (2014): White matter connectivity reflects clinical and cognitive status in Huntington's disease. Neurobiol Dis 65:180-187.
39. Reading SA, Yassa MA, Bakker A, Dziorny AC, Gourley LM, Yallapragada V, Rosenblatt A, Margolis RL, Aylward EH, Brandt J, Mori S, van Zijl P, Bassett SS, Ross CA (2005): Regional white matter change in pre-symptomatic Huntington's disease: A diffusion tensor imaging study. Psychiatry Res 140:55-62.
40. Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME, Caplan K, Marek K, Seidman LJ, Makris N, Jenkins BG, Goldstein JM (2003): Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis. Neurology 60:1615-1620.
41. Rosas HD, Tuch DS, Hevelone ND, Zaleta AK, Vangel M, Hersch SM, Salat DH (2006): Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures. Mov Disord 21:1317-1325.
42. Rosas HD, Lee SY, Bender AC, Zaleta AK, Vangel M, Yu P, Fischl B, Pappu V, Onorato C, Cha JH, Salat DH, Hersch SM (2010): Altered white matter microstructure in the corpus callosum in Huntington's disease: Implications for cortical. Neuroimage 49:2995-3004.
43. Saft C, Schuttke A, Beste C, Andrich J, Heindel W, Pfleiderer B (2008): fMRI reveals altered auditory processing in manifest and premanifest Huntington's disease. Neuropsychologia 46:1279-1289.
44. Sah DW, Aronin N (2011): Oligonucleotide therapeutic approaches for Huntington disease. J Clin Invest 121:500-507.
45. Seppi K, Schocke MF, Mair KJ, Esterhammer R, Weirich-Schwaiger H, Utermann B, Egger K, Brenneis C, Granata R, Boesch S, Poewe W, Wenning GK (2006): Diffusion-weighted imaging in Huntington's disease. Mov Disord 21:1043-1047.
46. Seunarine KK, Alexander DC (2013): Multiple fibers: beyond the diffusion tensor. In: Behrens, TEJ, Johansen-Berg, H (eds) Diffusion MRI: From Quantitative Measurement to In vivo Neuroanatomy, 2nd ed., Academic Press, San Diego. pp 105-123.
47. Smith A (1968): The Symbol Digit Modalities Test: A neuropsychologic test for economic screening of learning and other cerebral disorders. Learn Disord 3:83-91.
48. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004): Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23 Suppl 1:S208-S219.
49. Sritharan A, Egan G, Johnston L, Horne M, Bradshaw J, Bohanna I, Asadi H, Cunnington R, Churchyard AJ, Chua P, Farrow M, Georgiou-Karistianis N (2010): A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease. J Neurol Neurosurg Psychiatry 81:257-262.
50. Stoffers D, Sheldon S, Kuperman J, Goldstein J, Corey-Bloom J, Aron A (2010): Contrasting gray and white matter changes in preclinical Huntington disease. Neurology 74:1208.
51. Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC; TRACK-HD investigators (2009): Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data. Lancet Neurol 8:791-801.
52. Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC; TRACK-HD Investigators (2011): Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: The 12-month longitudinal analysis. Lancet Neurol 10:31-42.
53. Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR; TRACK-HD investigators (2012): Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: Analysis of 24 month observational data. Lancet Neurol 11:42-53.
54. Tournier JD, Calamante F, Connelly A (2007): Robust determination of the fibre orientation distribution in diffusion MRI: Non-negativity constrained super-resolved spherical deconvolution. NeuroImage 35:1459-1472.
55. Vandenberghe W, Demaerel P, Dom R, Maes F (2009): Diffusion-weighted versus volumetric imaging of the striatum in early symptomatic Huntington disease. J Neurol 256:109-114.
56. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP, Jr. (1985): Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44:559-577.
57. Weaver KE, Richards TL, Liang O, Laurino MY, Samii A, Aylward EH (2009): Longitudinal diffusion tensor imaging in Huntington's Disease. Exp Neurol 216:525-529.
58. Wolf RC, Sambataro F, Vasic N, Schonfeldt-Lecuona C, Ecker D, Landwehrmeyer B (2008a): Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease. Exp Neurol 213:137-144.
59. Wolf RC, Sambataro F, Vasic N, Schonfeldt-Lecuona C, Ecker D, Landwehrmeyer B (2008b): Altered frontostriatal coupling in pre-manifest Huntington's disease: Effects of increasing cognitive load. Eur J Neurol 15:1180-1190.
60. Young AW, Perrett D, Calder AJ; Sprengelmayer R, Ekman P (2002): Facial expressions of emotion: Stimuli and tests (FEEST). Psychology. Thames Valley Test Company, Bury St Edmunds, England.
61. Zigmond AS, Snaith RP (1983): The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370.
62. Zimbelman JL, Paulsen JS, Mikos A, Reynolds NC, Hoffmann RG, Rao SM (2007): fMRI detection of early neural dysfunction in preclinical Huntington's disease. J Int Neuropsychol Soc 13:758-769.